Join the Oncology Voice Network. Join for Free
How to Create a GREAT MSL Team Culture
Chad Fellers team dynamics in medical affairs team-centric culture fostering development recruiting for cultural fit

How to Create a GREAT MSL Team Culture


Share This Article


Summary

In this episode, Chad Fellers joins to discuss the crucial elements of team dynamics and leadership in medical affairs. Chad shares insights into his background, emphasizing the importance of a team-centric culture and how positive intent in communication extends beyond the workplace. The conversation delves into the significance of trust, fostering development, and recruiting for cultural fit to ensure career satisfaction. Chad also reflects on adapting team culture during the pandemic, offering practical strategies. The episode concludes with a nod to the podcast's mission and encouragement for listener engagement.

Chad Fellers, Director, Medical Science Liaisons at Harmony Biosciences discusses how to develop a GREAT MSL team culture.

Chad shares…

πŸ‘‰ His strategy, philosophy, and key ingredients for a great team culture

πŸ‘‰ Why culture is so important and the benefits of a great culture

πŸ‘‰ Why a “sense of ownership” is so important

πŸ‘‰ How the pandemic and the virtual world affected the team culture

πŸ‘‰ His “Lead vs manage” philosophy and how to cater to the individual team member for career satisfaction

Click for Source
Chad Fellers, team dynamics in medical affairs, team-centric culture, fostering development, recruiting for cultural fit

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Article
Median Survival or Mean Survival: Which Measure Is the Most Appropriate for Patients, Physicians, and Policymakers?
OVN Avatar Omer Ben‐Aharon, Racheli Magnezi, Moshe Leshno, and Daniel A. Goldstein

Median Survival or Mean Survival: Which Measure Is the Most Appropriate for Patients, Physicians, and Policymakers?

Press Release
Announcing the Launch of Voices of Oncology: A Landmark Collaboration with Forbes
OVN Avatar OVN Staff

Announcing the Launch of Voices of Oncology: A Landmark Collaboration with Forbes

Press Release
Introducing OncologyVoiceNetwork.com
OVN Avatar OVN Staff

Introducing OncologyVoiceNetwork.com

Article
Updated estimates of eligibility for and response to genome-targeted oncology drugs among US cancer patients, 2006-2020
OVN Avatar A. Haslam, M.S. Kim, V. Prasad

Updated estimates of eligibility for and response to genome-targeted oncology drugs among US cancer patients, 2006-2020

Podcast
The Ideal Roadmap for New MSLs
Partner Avatar MSL Talk: Tom Caravela, Sarah Snyder

The Ideal Roadmap for New MSLs

Article
Biases in study design, implementation, and data analysis that distort the appraisal of clinical benefit and ESMO-Magnitude of Clinical Benefit Scale (ESMO-MCBS) scoring
OVN Avatar B. Gyawali, E. G. E. de Vries, U. Dafni, T. Amaral, J. Barriuso, J. Bogaerts, A. Calles, G. Curigliano, C. Gomez-Roca, B. Kiesewetter, S. Oosting, A. Passaro, G. Pentheroudakis, M. Piccart, F. Roitberg, J. Tabernero, N. Tarazona, D. Trapani, R. Wester, G.

Biases in study design, implementation, and data analysis that distort the appraisal of clinical benefit and ESMO-Magnitude of Clinical Benefit Scale (ESMO-MCBS) scoring

Explore OVN